Prevalence of Kidney Stones in Mainland China: A Systematic Review

Overview

Journal Sci Rep

Specialty Science

Date 2017 Feb 1

PMID 28139722

Citations 91

Authors

Wenying Wang

Jingyuan Fan

Guifeng Huang

Jun Li

Xi Zhu

Ye Tian

Li Su

Affiliations

Soon will be listed here.

Abstract

The data on the prevalence of kidney stones in mainland China are still lacking. We performed the present meta-analysis to assess the stone prevalence in mainland China from 1990 through 2016. A total of 18 articles were included. The pooled overall prevalence was 7.54% (95% CI, 5.94-9.15). The prevalence in age groups of <20 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, and 60 years and older was 0.27%, 3.15%, 5.96%, 8.18%, 9.14%, and 9.68%, respectively, showing that it increased with age. Moreover, the prevalence was 10.34% in males and 6.62% in females, with an odds ratio (OR) of 1.63 [95% CI: 1.51-1.76], indicating that males are more likely to suffer from this disease than females. However, urban areas (6.03%, 95% CI: 3.39-8.68) and rural areas (7.48%, 95% CI: 3.39-11.57) did not differ in the stone prevalence rate (OR = 0.84, 95% CI: 0.42-1.68). The prevalence in the year groups of 1991-2000, 2001-2010, and 2011 to date was 5.95%, 8.86%, and 10.63%, respectively, which indicated an increasing trend. Further high-quality surveys throughout mainland China are needed to confirm these findings.

Citing Articles

Prevalence and Factors Associated with Kidney Stones in the Elderly Iranian Population: Findings from the Ardakan Cohort Study on Aging (ACSA).

Delbari A, Farrokhi M, Mehri A, Saberian M, Sadri M, Saatchi M Arch Iran Med. 2025; 28(2):73-80.

PMID: 40062494 PMC: 11892097. DOI: 10.34172/aim.33337.

Dietary index for gut microbiota and its protective role against kidney stones: evidence of diabetes as a mediator from NHANES cross-sectional data.

Wang L, Wu J, Jiang Z, Wang C, Lin F, Zhong Y Front Nutr. 2025; 12:1532313.

PMID: 40008311 PMC: 11852834. DOI: 10.3389/fnut.2025.1532313.

Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation.

Shi M, Su X, Xiang H, Song Q, Yang S Urolithiasis. 2025; 53(1):27.

PMID: 39932538 DOI: 10.1007/s00240-025-01703-6.

Constructing a machine learning model for systemic infection after kidney stone surgery based on CT values.

Li J, Du Y, Huang G, Huang Y, Xi X, Ye Z Sci Rep. 2025; 15(1):4327.

PMID: 39910162 PMC: 11799361. DOI: 10.1038/s41598-025-88704-y.

UHRF1 promotes calcium oxalate-induced renal fibrosis by renal lipid deposition via bridging AMPK dephosphorylation.

Sun Y, Li B, Song B, Xia Y, Ye Z, Lin F Cell Biol Toxicol. 2025; 41(1):39.

PMID: 39899077 PMC: 11790803. DOI: 10.1007/s10565-025-09991-9.

References

Curhan G, Curhan S . Dietary factors and kidney stone formation. Compr Ther. 1994; 20(9):485-9. View

Matthews S, Lancaster J . Urinary tract infections in the elderly population. Am J Geriatr Pharmacother. 2011; 9(5):286-309. DOI: 10.1016/j.amjopharm.2011.07.002. View

Pearle M, Calhoun E, Curhan G . Urologic diseases in America project: urolithiasis. J Urol. 2005; 173(3):848-57. DOI: 10.1097/01.ju.0000152082.14384.d7. View

Kirkali Z, Rasooly R, Star R, Rodgers G . Urinary Stone Disease: Progress, Status, and Needs. Urology. 2015; 86(4):651-3. PMC: 4592788. DOI: 10.1016/j.urology.2015.07.006. View

He L, Ren X, Qian Y, Jin Y, Chen Y, Guo D . Prevalence of overweight and obesity among a university faculty and staffs from 2004 to 2010 in Wuhu, China. Nutr Hosp. 2014; 29(5):1033-7. DOI: 10.3305/nh.2014.29.5.7354. View

Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

Lee Y, Huang W, Tsai J, Lu C, Chen W, Lee M . Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int. 2002; 68(3):172-7. DOI: 10.1159/000048445. View

Curhan G . Epidemiology of stone disease. Urol Clin North Am. 2007; 34(3):287-93. PMC: 2693870. DOI: 10.1016/j.ucl.2007.04.003. View

Sakhaee K, Maalouf N, Sinnott B . Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012; 97(6):1847-60. PMC: 3387413. DOI: 10.1210/jc.2011-3492. View

10.

Galvin D, Pearle M . The contemporary management of renal and ureteric calculi. BJU Int. 2006; 98(6):1283-8. DOI: 10.1111/j.1464-410X.2006.06514.x. View

11.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014; 12(12):1495-9. DOI: 10.1016/j.ijsu.2014.07.013. View

12.

Perera M, Papa N, Kinnear N, Wetherell D, Lawrentschuk N, Webb D . Urolithiasis Treatment in Australia: The Age of Ureteroscopic Intervention. J Endourol. 2016; 30(11):1194-1199. DOI: 10.1089/end.2016.0513. View

13.

Romero V, Akpinar H, Assimos D . Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12(2-3):e86-96. PMC: 2931286. View

14.

Stamatelou K, Francis M, Jones C, Nyberg L, Curhan G . Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63(5):1817-23. DOI: 10.1046/j.1523-1755.2003.00917.x. View

15.

Durner L, Bach C, El Howairis M, Hakenberg O, Buchholz N . Current Trends in Urolithiasis Treatment in Various European Health Systems. Urol Int. 2015; 96(2):125-31. DOI: 10.1159/000441041. View

16.

Scales Jr C, Curtis L, Norris R, Springhart W, Sur R, Schulman K . Changing gender prevalence of stone disease. J Urol. 2007; 177(3):979-82. DOI: 10.1016/j.juro.2006.10.069. View

17.

Sancak E, Resorlu M, Akbas A, Gulpinar M, Arslan M, Resorlu B . Do Hypertension, diabetes mellitus and obesity increase the risk of severity of nephrolithiasis?. Pak J Med Sci. 2015; 31(3):566-71. PMC: 4485272. DOI: 10.12669/pjms.313.7086. View

18.

Hesse A, Brandle E, Wilbert D, Kohrmann K, Alken P . Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003; 44(6):709-13. DOI: 10.1016/s0302-2838(03)00415-9. View

19.

Alexander R, Hemmelgarn B, Wiebe N, Bello A, Morgan C, Samuel S . Kidney stones and kidney function loss: a cohort study. BMJ. 2012; 345:e5287. PMC: 3431443. DOI: 10.1136/bmj.e5287. View

20.

Yoshimura E, Sawada S, Lee I, Gando Y, Kamada M, Matsushita M . Body Mass Index and Kidney Stones: A Cohort Study of Japanese Men. J Epidemiol. 2015; 26(3):131-6. PMC: 4773489. DOI: 10.2188/jea.JE20150049. View